X @Forbes
Forbes·2025-10-01 20:14
The pharmaceutical giant’s deal with Trump to cut prices has little impact on the bottom line–but removes a lot of regulatory uncertainty. Investors love it.https://t.co/4kLjFDNWlJhttps://t.co/4kLjFDNWlJ ...
The pharmaceutical giant’s deal with Trump to cut prices has little impact on the bottom line–but removes a lot of regulatory uncertainty. Investors love it.https://t.co/4kLjFDNWlJhttps://t.co/4kLjFDNWlJ ...